What iron bisglycinate dose (elemental iron) is recommended for a patient with a ferritin level of 2 µg/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Iron Bisglycinate Dose for Ferritin of 2 µg/L

For a ferritin level of 2 µg/L (severe iron deficiency), start with 25-30 mg of elemental iron from ferrous bisglycinate once daily, taken with vitamin C to enhance absorption. 1

Dosing Algorithm

Initial Approach

  • Start with 25-30 mg elemental iron once daily (this equals approximately one 157 mg ferrous bisglycinate tablet, which contains 30 mg elemental iron) 2
  • Take 30 minutes before meals 2
  • Add vitamin C supplementation to improve absorption 1
  • Consider every-other-day dosing if gastrointestinal side effects occur, as this maintains similar absorption rates with better tolerability 1

Rationale for This Dose

The 2024 AGA guidelines emphasize that no single oral iron formulation has advantages over others, but ferrous bisglycinate offers specific benefits 1. With your critically low ferritin of 2 µg/L (well below the 15 µg/L threshold for iron deficiency), you need effective repletion but must balance this against tolerability to ensure adherence.

Recent high-quality evidence demonstrates that:

  • 25-30 mg elemental iron from bisglycinate is as effective as 50 mg from ferrous sulfate for preventing and treating iron deficiency 3
  • Lower doses (27 mg) successfully restore iron status in iron-deficient individuals 4
  • 60 mg daily provides faster repletion but may not be necessary initially 5

Escalation Strategy

If ferritin fails to improve after 4-6 weeks on 25-30 mg daily:

  1. Increase to 60 mg elemental iron daily (two tablets of 30 mg each) 5, 2
  2. If still no response or intolerance develops, switch to intravenous iron 1

When to Consider IV Iron Instead

Strongly consider IV iron from the start if:

  • History of bariatric surgery (especially Roux-en-Y gastric bypass) 1
  • Active inflammatory bowel disease 1
  • Previous intolerance to oral iron 1
  • Ongoing blood loss exceeding oral absorption capacity 1

Monitoring and Duration

  • Recheck ferritin and hemoglobin at 4-6 weeks to assess response
  • Continue supplementation until ferritin reaches at least 30-50 µg/L (typically 8-12 weeks minimum) 5, 2
  • Once daily dosing is sufficient—more frequent dosing doesn't improve absorption and increases side effects 1

Critical Safety Considerations

Tolerability Advantage

Ferrous bisglycinate demonstrates significantly lower gastrointestinal side effects compared to ferrous sulfate:

  • Nausea: 8.3% vs 24.1% 2
  • Constipation: 3.3% vs 13.0% 2
  • Abdominal pain: 3.3% vs 16.7% 2

This improved tolerability translates to better adherence and treatment completion, which is crucial for someone with such severe deficiency 2.

Pediatric Safety Warning

Keep iron supplements away from children—accidental overdose is a leading cause of fatal poisoning in children under 6 6.

Common Pitfalls to Avoid

  1. Don't prescribe twice-daily dosing initially—once daily or every-other-day is equally effective with better tolerance 1
  2. Don't use ferrous sulfate at standard 105 mg doses—bisglycinate at 25-30 mg provides similar efficacy with fewer side effects 7
  3. Don't forget vitamin C co-administration—this significantly enhances absorption 1
  4. Don't continue oral iron indefinitely without reassessment—if no improvement by 6-8 weeks, switch to IV iron rather than persisting with oral therapy 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.